IP Library Granted Patent US 11,511,109
Granted Patent B2
US 11,511,109 · App. 16/278,945 · Granted Nov 29, 2022

Non-invasive magnetic or electrical nerve stimulation to treat gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders

Inventors: Bruce J. Simon (Mountain Lakes, NJ); Joseph P. Errico (Warren, NJ); John T. Raffle (Austin, TX)
Assignee: ELECTROCORE, INC.
A61N1/36007A61N1/0456A61N1/36A61N1/36014A61N2/006A61N2/02A61N1/205A61N1/36034A61N1/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,511,109
App. No.
16/278,945
Granted
Nov 29, 2022
Kind
B2
Abstract

Devices, systems and methods are disclosed for treating or preventing gastroparesis, functional dyspepsia, and other functional gastrointestinal disorders. The methods comprise transmitting impulses of energy non-invasively to selected nerve fibers, particularly those in a vagus nerve. The methods provide damaged interstitial cells of Cajal (ICC) with trophic factors via vagal afferent nerve fibers, thereby reversing ICC damage, and as a consequence improving gastric motility. The methods also increase levels of inhibitory neurotransmitters in the brain so as to decrease neural activity within the area postrema, or they deactivate a resting state neural network containing parts of the anterior insula and anterior cingulate cortex, which will thereby reduce abnormal interoception and visceral hypersensitivity.

Claims (13)

1. A method comprising:

contacting an interface against an outer skin surface of a patient, wherein the interface is part of a housing, wherein the housing includes an electrode and an energy source, wherein the electrode is coupled to the energy source and the interface;

generating an electric current at the electrode via the energy source; and

transmitting the electric current from the electrode, through the interface and the outer skin surface, to a vagus nerve within the patient as the interface is in contact with the outer skin surface, wherein the electric current has a frequency of about 1 KHz to about 10 KHz and is configured to modulate the vagus nerve to at least one of treat or prevent at least one of a gastroparesis, a functional dyspepsia, or an ileus in the patient.

2. The method of claim 1 , wherein the electric current comprises bursts of pulses having a frequency from about 1 burst per second to about 100 bursts per second.

3. The method of claim 2 , wherein each of the pulses has a duration from about 100 microseconds to about 1,000 microseconds.

4. The method of claim 2 , wherein each of the pulses has a duration from about 200 microseconds to about 400 microseconds.

5. The method of claim 1 , wherein the frequency of the electric current is about 4 KHz to about 6 KHZ.

6. The method of claim 1 , wherein the electric current has a duty cycle from about 1% to about 10%.

7. The method of claim 1 , wherein the electric current generates an electric field at a vagus nerve of the patient above a threshold of generating an action potential within a fiber of the vagus nerve responsible for activating a neural pathway causing a release of an inhibitory neurotransmitter within a brain of the patient.

8. The method of claim 7 , wherein the inhibitory neurotransmitter includes at least one of a noreprinephrine, a serotonin, or a GABA.

9. The method of claim 7 , further comprising contacting the interface against an outer skin surface of a neck of a patient.

10. The method of claim 7 , further comprising contacting the interface against an outer skin surface of an ear of a patient.

Assignments (1)
SECURITY INTEREST Recorded Aug 12, 2025
From: ELECTROCORE, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 072452/0559 →
Continuity (8)
Division 14992398 · Jan 11, 2016
Division 13731035 · Dec 30, 2012
Continuation In Part 13222087 · Aug 31, 2011
Continuation In Part 13183765 · Jul 15, 2011
Continuation In Part 13075746 · Mar 30, 2011
Provisional Application 61488208 · May 20, 2011
Provisional Application 61451259 · Mar 10, 2011
Related Publication 20190184162A1 · Jun 20, 2019
Cited By (1)
US 12,357,817